Vehof J W M, Takita H, Kuboki Y, Spauwen P H M, Jansen J A
Department of Biomaterials, College of Dental Science, University Medical Center Nijmegen, P. O. Box 9101, the Netherlands.
J Biomed Mater Res. 2002 Sep 5;61(3):440-9. doi: 10.1002/jbm.10216.
On the basis of currently available knowledge, we hypothesize that the initial bone formation, as induced by bone morphogenetic protein (BMP), is influenced by the chemical composition and three-dimensional spatial configuration of the used carrier material. Therefore, in the current study, the osteoinductive properties of porous titanium (Ti) fiber mesh with a calcium phosphate (Ca-P) coating (Ti-CaP), insoluble bone matrix (IBM), fibrous glass membrane (FGM), and porous particles of hydroxy apatite (PPHAP) loaded with rhBMP-2 were compared in a rat ectopic assay model at short implantation periods. Twelve Ti-CaP, 12 IBM, 12 FGM, and 12 PPHAP implants, loaded with rhBMP-2, were subcutaneously placed in 16 Wistar King rats. The rats were sacrificed at 3, 5, 7, and 9 days post-operative, and the implants were retrieved. Histological analysis demonstrated that IBM and Ti-CaP had induced ectopic cartilage and bone formation by 5 and 7 days, respectively. However, in PPHAP, bone formation and cartilage formation were seen together at 7 days. At 9 days, in Ti-CaP, IBM, and PPHAP, cartilage was seen together with trabecular bone. At 9 days, in FGM, only cartilage was observed. Quantitative rating of the tissue response, using a scoring system, demonstrated that the observed differences were statistically significant (Wilcoxon rank sum test, p < 0.05). We conclude that IBM, CaP-coated Ti mesh, FGM, and PPHAP provided with rhBMP-2 can indeed induce ectopic bone formation with a cartilaginous phase in a rat model at short implantation periods. Considering the different chemical composition and three-dimensional spatial configuration of the carrier materials used, these findings even suggest that endochondral ossification is present in rhBMP-2-induced osteogenesis, even though the amount of cartilage may differ.
基于目前现有的知识,我们推测,由骨形态发生蛋白(BMP)诱导的初始骨形成受到所用载体材料的化学成分和三维空间构型的影响。因此,在本研究中,在大鼠异位试验模型中,比较了负载重组人骨形态发生蛋白-2(rhBMP-2)的磷酸钙(Ca-P)涂层多孔钛(Ti)纤维网(Ti-CaP)、不溶性骨基质(IBM)、纤维玻璃膜(FGM)和羟基磷灰石多孔颗粒(PPHAP)在短植入期的骨诱导特性。将12个负载rhBMP-2的Ti-CaP植入物、12个IBM植入物、12个FGM植入物和12个PPHAP植入物皮下植入16只Wistar King大鼠体内。术后3、5、7和9天处死大鼠,取出植入物。组织学分析表明,IBM和Ti-CaP分别在5天和7天时诱导了异位软骨和骨形成。然而,在PPHAP中,7天时同时观察到骨形成和软骨形成。9天时,在Ti-CaP、IBM和PPHAP中,软骨与小梁骨同时出现。9天时,在FGM中仅观察到软骨。使用评分系统对组织反应进行定量评分,结果表明观察到的差异具有统计学意义(Wilcoxon秩和检验,p<0.05)。我们得出结论,负载rhBMP-2的IBM、CaP涂层Ti网、FGM和PPHAP在大鼠模型的短植入期确实能够诱导具有软骨阶段的异位骨形成。考虑到所用载体材料不同的化学成分和三维空间构型,这些发现甚至表明,尽管软骨量可能不同,但在rhBMP-2诱导的骨生成中存在软骨内成骨。